2025-06-12-花旗集团-波兰保险集团（PZU）_PZU（PZU.WA）_有降至波兰银行市盈率倍数的风险；重申卖出评级_40页_1mb

PZU (PZU.WA) Summary

Core Content

PZU, a major Polish insurer, is currently facing challenges due to its complex group structure, which involves holding stakes in two banks. This structure is viewed as suboptimal and is expected to increase the capital burden, especially under new regulatory requirements. As a result, PZU has proposed a reorganization involving the creation of a HoldCo and a merger with Bank Pekao, aiming to reduce the negative impact of capital requirements and free up significant capital.

Main Views

• Group Structure Issues: The current structure of PZU Group, with the insurer controlling stakes in two banks, is considered inefficient. Regulatory changes are expected to increase the capital burden significantly.
• Proposed Solution: PZU plans to create a HoldCo and merge it with Bank Pekao, which could potentially free up ZI 15-20bn of capital. However, the execution of this plan is fraught with uncertainty.
• Execution Risks: The merger requires legal amendments, is complex, and involves uncertainty over share swap ratios and regulatory constraints. These risks could hinder the success of the plan.
• Capital Release Impact: If the merger is successful, the freed-up capital may not be fully distributed to shareholders due to regulatory limits on dividend payments.
• Valuation and Rating: Despite strong first-quarter earnings, Citi Research maintains its rating at Sell, with a target price of ZI 55.90. They believe the transaction may not unlock value and could instead lead to a de-rating toward Polish bank multiples.

Key Information

Financial Performance (2023A-2027E)

Market Valuation

Capital and Regulatory Impact

• The negative impact of holding banks on PZU's Solvency II ratio is expected to rise from <10 pp to >60 pp.
• The "Danish compromise" is a key factor in the capital benefit of the merger, allowing banks to apply a 250% risk weight to insurer stakes.
• The merger would result in a significant increase in Pekao's Tier 1 capital and lending capacity, but the growth in deposits may not be sufficient to fully capitalize on this.

Shareholder Impact

• The potential upside for PZU shareholders from the merger is estimated at 0% - 22%, assuming no execution risk and rapid capital deployment.
• The share swap parity is expected to be in the range of 0.26 - 0.29, which would reduce the upside for PZU shareholders compared to the current market price.

Summary of FY2024 and 1Q25 Results

• Strong performance in 1Q25 was driven by improved motor insurance profitability and strong life insurance results.
• The proposed merger with Pekao could lead to a restructuring of the group, but the execution risks are significant.
• The potential for the merger to de-rate PZU toward Polish bank multiples is a major concern, as it could negatively impact the stock's valuation.

Conclusion

Citi Research continues to rate PZU as Sell due to the high execution risk and uncertainty surrounding the proposed group structure changes. The potential benefits of the merger are not expected to outweigh the risks, and the company is still valued under the assumption that the capital group remains unchanged. The target price of ZI 55.90 reflects these concerns and the potential for a de-rating.